Marina Gold
General Practice · Glendale, CANPI 1770653974
Payments from drug & device makers
What this record shows
AstraZeneca accounts for 62.3% of it on its own, with 7 other manufacturers making up the rest. Reporting peaked in 2024 at $389 and has fallen 92.2% since, to $30 in 2025.
Across 17 payments — averaging $48.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$514
- Amarin Pharma, Inc.$119
- Nestle Healthcare Nutrition Inc.$48
- Novo Nordisk$46
- Shield Therapeutics Inc$30
- Amgen$26
- plus $41 from 2 others
Across 139 payments — averaging $5631.92 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- AstraZeneca$379K
- Gilead$171K
- Sanofi US Services Inc.$107K
- Boehringer Ingelheim$54K
- Astrazeneca UK Limited$40K
- Bayer$21K
- plus $12K from 3 others
What the payments were for
- Travel & lodging$37045%
- Food & beverage$45555%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 4 | $514 |
| Amarin Pharma, Inc. | 5 | $119 |
| Nestle Healthcare Nutrition Inc. | 2 | $48 |
| Novo Nordisk | 2 | $46 |
| Shield Therapeutics Inc | 1 | $30 |
| Amgen | 1 | $26 |
| GSK | 1 | $21 |
| Lilly USA, LLC | 1 | $21 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- FARXIGA$125
How this compares
$825 in reported general payments places this provider in the 75th percentile of 12,963 general practice providers in California.
Other general practice in Glendale
- Nathan LiLancaster$5.2M
- Milton McCollSan Jose$4.9M
- Frederic MollRedwood City$2.5M
- Bradley ChingUpland$1.4M
- Eric BrassTorrance$755K
- Marc GeissbergerGreenbrae$583K
- Robert CampbellLong Beach$501K
- Varo BoyerNorth Hills$482K
- Michael MiyasakiSacramento$464K
- Apolinar MadrigalCeres$419K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.